Valuation: CStone Pharmaceuticals

Market Cap 654.13Cr 97Cr 85Cr 78Cr 72Cr 136.17Cr 9.3TCr 137.82Cr 936.37Cr 366.42Cr 4.56TCr 362.63Cr 354.83Cr 16TCr P/E 2026 *
-307x
P/E 2027 * 6.11x
Enterprise Value 601.31Cr 89Cr 78Cr 72Cr 66Cr 125.17Cr 8.55TCr 126.69Cr 860.76Cr 336.83Cr 4.19TCr 333.35Cr 326.18Cr 14TCr EV / Sales 2026 *
12.5x
EV / Sales 2027 * 1.71x
Free-Float
77.71%
Yield 2026 *
-
Yield 2027 * -

Last Transcript: CStone Pharmaceuticals

1 day+19.43%
Current month+19.43%
1 month+19.43%
3 months-29.70%
6 months-17.29%
Current year-20.49%
1 month 0.71
Extreme 0.71
0.71
Current year 0.59
Extreme 0.5945
1.01
1 year 0.59
Extreme 0.5945
1.01
3 years 0.11
Extreme 0.1139
1.01
5 years 0.11
Extreme 0.1139
1.95
10 years 0
Extreme 0.0001
2.6
Manager TitleAgeSince
Chief Executive Officer 62 25/08/2022
Director of Finance/CFO - 18/01/2023
Chief Operating Officer 46 01/08/2016
Director TitleAgeSince
Chairman 55 -
Director/Board Member 62 25/08/2022
Director/Board Member 63 09/07/2021
Change 5-day change 1-year change 3-year change Capi.($)
+19.43%0.00% - - 95Cr
-1.03%+0.40%+18.93%-8.26% 6.87TCr
-0.25%+3.22%+41.00%+198.82% 5.3TCr
-1.65%+37.20%+37.20%+37.20% 4.36TCr
-2.83%-4.08%-53.81%-55.84% 4.07TCr
-0.48%+1.83%+57.09%-27.49% 3TCr
-0.25%-12.81%+81.88%-51.61% 2.37TCr
-0.07%+1.98%+70.34%+84.94% 2.35TCr
+0.11%+2.44%+4.06%+181.25% 2.05TCr
-0.39%+1.54%+71.10%+126.52% 1.67TCr
Average +1.25%+0.67%+36.42%+53.95% 3.56TCr
Weighted average by Cap. -0.88%+1.22%+29.57%+47.07%

Financials

2026 *2027 *
Net sales 48Cr 7.08Cr 6.2Cr 5.75Cr 5.29Cr 9.98Cr 681.72Cr 10Cr 69Cr 27Cr 334.1Cr 27Cr 26Cr 1.15TCr 171.33Cr 25Cr 22Cr 21Cr 19Cr 36Cr 2.44TCr 36Cr 245.25Cr 96Cr 1.19TCr 95Cr 93Cr 4.12TCr
Net income -24Cr -3.59Cr -3.15Cr -2.92Cr -2.68Cr -5.06Cr -345.91Cr -5.12Cr -35Cr -14Cr -169.52Cr -13Cr -13Cr -585.33Cr 69Cr 10Cr 8.9Cr 8.25Cr 7.59Cr 14Cr 977.74Cr 14Cr 98Cr 39Cr 479.17Cr 38Cr 37Cr 1.65TCr
Net Debt -53Cr -7.8Cr -6.84Cr -6.34Cr -5.83Cr -11Cr -751.25Cr -11Cr -76Cr -30Cr -368.18Cr -29Cr -29Cr -1.27TCr -360.31Cr -53Cr -47Cr -43Cr -40Cr -75Cr -5.12TCr -76Cr -515.77Cr -201.83Cr -2.51TCr -199.75Cr -195.45Cr -8.67TCr
Logo CStone Pharmaceuticals
CStone Pharmaceuticals is an investment holding company primarily engaged in research and development of therapies for oncology, autoimmune and inflammation, and other key disease areas. Through its subsidiaries, the Company is primarily engaged in the research and development of biopharmaceutical products, the sales of pharmaceutical products, as well as the provision of license of its intellectual property (IP) or commercialization license. The Company’s products primarily include targeted therapies, AYVAKIT (avapritinib), GAVRETO (pralsetinib) and CEJEMLY (sugemalimab). The Company is also engaged in the development and commercialization of immuno-oncology. The Company primarily conducts its businesses in the domestic market and overseas markets, such as Central and Eastern Europe and Switzerland.
Employees
136
Trader
Investor
-
Global
-
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
4.093CNY
Average target price
12.38CNY
Spread / Average Target
+202.43%

Quarterly revenue - Rate of surprise